BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.41 Cr | ₹1.55 Cr | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.41 Cr |
| Mar2024 | ₹1.55 Cr |
| Mar2023 | ₹0.70 Cr |
| Mar2022 | ₹0.60 Cr |
| Mar2021 | ₹2.63 Cr |
How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.41 Cr | Negative | |
| Mar2024 | ₹1.55 Cr | 120.34 | |
| Mar2023 | ₹0.70 Cr | 16.39 | |
| Mar2022 | ₹0.60 Cr | -77.05 | |
| Mar2021 | ₹2.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹139.3 Cr | -2% | 0.1% | -7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2% |
0.1% |
-7.9% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses